Skip to main content
. 2022 Nov 3;36(6):2780–2789. doi: 10.21873/invivo.13015

Figure 2. Log10(anti-spike protein antibody levels) U/ml at baseline, Time point A (just before the second BNT162b2 vaccination), Time point B (1 month after the second NT162b2 vaccination), and Time point C (3 months after the second BNT162b2 vaccination) for all cases.

Figure 2